Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62009TJ0289

    Judgment of the General Court (First Chamber) of 9 September 2011.
    Omnicare, Inc. v Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM).
    Community trade mark - Opposition proceedings - Application for Community word mark OMNICARE CLINICAL RESEARCH - Earlier national figurative mark OMNICARE - Likelihood of confusion - Similarity of the signs - Similarity of the services - Genuine use of the earlier mark.
    Case T-289/09.

    European Court Reports 2011 II-00270*

    ECLI identifier: ECLI:EU:T:2011:452





    Judgment of the General Court (First Chamber) of 9 September 2011 – Omnicare v OHIM – Astellas Pharma (OMNICARE CLINICAL RESEARCH)

    (Case T-289/09)

    Community trade mark – Opposition proceedings – Application for Community word mark OMNICARE CLINICAL RESEARCH – Earlier national figurative mark OMNICARE – Likelihood of confusion – Similarity of the signs – Similarity of the services – Genuine use of the earlier mark

    Community trade mark – Definition and acquisition of the Community trade mark – Relative grounds for refusal – Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services – Likelihood of confusion with the earlier mark (Council Regulation No 207/2009, Art. 8(1)(b)) (see para. 95)

    Re:

    ACTION against the decision of the Fourth Board of Appeal of OHIM of 14 May 2009 (Case R 401/2008-4), concerning opposition proceedings between Yamanouchi Pharma GmbH and Omnicare, Inc.

    Operative part

    The Court:

    1.

    Dismisses the action;

    2.

    Orders Omnicare, Inc. to pay the costs.

    Top